Dr. Carlos Barron is a molecular biologist with basic medical training and research experience in both academic institutions and in the biotechnology and pharmaceutical industries, primaily in the oncology field.
He is an expert in integrating medical with molecular biological knowledge. Experience in company start-ups, management, consulting and academic teaching complete his profile.
Dr. Barron studied at the Faculty of Medicine and the Faculty of Sciences of the University Cayetano Heredia (Lima), graduating with a Bachelor of Science. He received a PhD in Molecular Biology from the University of Konstanz and worked at the Max Planck Institute of Biochemistry (Germany) and the University of Milan (Italy) with research grants from the German Academic Exchange Service, the Max Planck Society and the International Centre for Genetic Engineering and Biotechnology of the U.N.
At the end of the 1990's he joined R&D Oncology of Roche/Boehringer Mannheim. After that he was QC/QA head of MolMed and later co-founder and Director of Research and Operations of Arevia GmbH. Since 2010 he has been Managing Director of Barron Biomedical (Berlin) and is also engaged in consultancy and teaching activities.
Dr. Barron is a member of the German Cancer Society, the European Association for Cancer Research, the German Society of Pathology, the German Society of Human Genetics, and other institutions. For three consecutive years he received a Global Health & Pharma Award honoring his achievements in Precision Oncology (see 2018, 2019 and 2020)